N-[amino(imino)methyl]morpholine-4-carboximidamide hydrochloride, 95.0%, 25g

(R)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, 95%, 250mg

4-Bromo-2,6-dimethylanisole, 98.0%, 25g

2-Aminopyrimidine-5-carboxylic acid, 95.0%, 5g

3-Benzyl-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide, 99+%, 10mg

1-[2-(difluoromethyl)pyridin-4-yl]ethan-1-one, 95%, 100mg

2,7-Diiodofluorene>98.0%(GC)5g

3-(Chloromethyl)-1,2,4-oxadiazole, 97.0%, 2.5g

6-AMINO-2-(TRIFLUOROMETHYL)PYRIMIDIN-4-OL, 95.0%, 500mg

4-Chloroindole-3-acetic acid, 95.0%, 10g

N-(4-Hydroxyphenethyl)acetamide, 95.0%, 10g

1,1-DIFLUORO-3-(IODOMETHYL)CYCLOBUTANE, 95.0%, 100mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 500 ml, 130 mm, 1 Piece